Henry Hagopian Iii is Chief Financial Officer of Annovis Bio, Inc.. Currently has a direct ownership of 1,824 shares of ANVS, which is worth approximately $15,923. The most recent transaction as insider was on Nov 20, 2023, when has been sold 824 shares (Common Stock) at a price of $6.07 per share, resulting in proceeds of $5,001. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.82K
0% 3M change
82.4% 12M change
Total Value Held $15,923

Henry Hagopian III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2023
BUY
Grant, award, or other acquisition
$5,001 $6.07 p/Share
824 Added 31.12%
1,824 Common Stock
Apr 07 2023
BUY
Grant, award, or other acquisition
$12,610 $12.61 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

ORGO
Organogenesis Holdings Inc. Healthcare
HHI

Henry Hagopian Iii

Chief Financial Officer
Berwyn, PA

Track Institutional and Insider Activities on ANVS

Follow Annovis Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANVS shares.

Notify only if

Insider Trading

Get notified when an Annovis Bio, Inc. insider buys or sells ANVS shares.

Notify only if

News

Receive news related to Annovis Bio, Inc.

Track Activities on ANVS